IPCA - Capital Telefolio

Ipca Laboratories is a backward integrated, fast growing pharmaceutical
major, with a strong thrust on exports. It has reported 25% jump in net
sales and a whopping 102% rise in net profit in September 2006 quarter.
As the sales growth for the second half is expected to continue over
25% with much better profit margins, the company's financials are set for
a major uptrend.


Actual EPS for March 2005 : Rs 31.4
Actual EPS for March 2006 : Rs 25.6
Projected EPS for March 2007: Rs 38.1